New lotion for Kids' psoriasis under the microscope

NCT ID NCT03988439

Completed Symptom relief Sponsor: Bausch Health Americas, Inc. Source: ClinicalTrials.gov ↗

First seen Apr 24, 2026 · Last updated Jun 13, 2026 · Updated 9 times

Summary

This study looked at how a prescription lotion (IDP-118) works in children aged 4 to 16 with moderate to severe plaque psoriasis. Researchers measured how much of the drug enters the bloodstream and whether it affects the body's stress hormone system (HPA axis). The goal was to check safety and absorption, not to cure the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Bausch Site 1

Henderson, Nevada, 89052, United States
Bausch Site 11

Miami, Florida, 33173, United States
Bausch Site 12

Santo Domingo, Dominican Republic
Bausch Site 2

Panama City, Panama
Bausch Site 3

Louisville, Kentucky, 40217, United States
Bausch Site 4

Murray, Utah, 84123, United States
Bausch Site 5

San Antonio, Texas, 78213, United States
Bausch Site 6

Saint Joseph, Missouri, 64506, United States
Bausch Site 7

Doral, Florida, 33166, United States

Conditions

Explore the condition pages connected to this study.

PSORIASIS